Barbara Ruskin - Mar 24, 2023 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Anthony Mack, attorney-in-fact
Stock symbol
VRPX
Transactions as of
Mar 24, 2023
Transactions value $
$0
Form type
4
Date filed
3/28/2023, 08:05 PM
Next filing
Jan 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +25K $0.00 25K Mar 24, 2023 Common Stock 25K $0.84 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.